These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15058313)

  • 21. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.
    Gentile S
    Drug Saf; 2006; 29(4):303-19. PubMed ID: 16569080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.
    Cohen D; Bonnot O; Bodeau N; Consoli A; Laurent C
    J Clin Psychopharmacol; 2012 Jun; 32(3):309-16. PubMed ID: 22544019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
    Toren P; Ratner S; Laor N; Weizman A
    Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
    Maayan L; Correll CU
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
    Basson BR; Kinon BJ; Taylor CC; Szymanski KA; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Apr; 62(4):231-8. PubMed ID: 11379836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review.
    Simon V; van Winkel R; De Hert M
    J Clin Psychiatry; 2009 Jul; 70(7):1041-50. PubMed ID: 19653979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.
    Nasrallah HA
    Mol Psychiatry; 2008 Jan; 13(1):27-35. PubMed ID: 17848919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bodyweight gain with atypical antipsychotics. A comparative review.
    Wetterling T
    Drug Saf; 2001 Jan; 24(1):59-73. PubMed ID: 11219487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
    Chen CH; Huang MC; Lu ML
    J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
    [No Abstract]   [Full Text] [Related]  

  • 33. [Atypical antipsychotic induced weight gain and metabolic disorders].
    Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
    Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.
    Hong CJ; Liou YJ; Bai YM; Chen TT; Wang YC; Tsai SJ
    Pharmacogenet Genomics; 2010 Jun; 20(6):359-66. PubMed ID: 20375926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotic induced weight gain: pathophysiology and management.
    Ananth J; Venkatesh R; Burgoyne K; Gadasalli R; Binford R; Gunatilake S
    Ann Clin Psychiatry; 2004; 16(2):75-85. PubMed ID: 15328901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?
    Baptista T; Beaulieu S
    Can J Psychiatry; 2002 Oct; 47(8):742-9. PubMed ID: 12420652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight gain associated with antipsychotic drugs.
    Ganguli R
    J Clin Psychiatry; 1999; 60 Suppl 21():20-4. PubMed ID: 10548138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic side effects of antipsychotic medication.
    Tschoner A; Engl J; Laimer M; Kaser S; Rettenbacher M; Fleischhacker WW; Patsch JR; Ebenbichler CF
    Int J Clin Pract; 2007 Aug; 61(8):1356-70. PubMed ID: 17627711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.
    Wang LJ; Ree SC; Huang YS; Hsiao CC; Chen CK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():260-6. PubMed ID: 23085073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.